NO20001421L - T-cellevaksinasjon for behandling av multippel sklerose - Google Patents

T-cellevaksinasjon for behandling av multippel sklerose

Info

Publication number: NO20001421L
Authority: NO; Norway
Prior art keywords: treatment; multiple sclerosis; cells; disclosed; methods
Prior art date: 1997-09-19

Application number

NO20001421A

Other languages

English (en)

Other versions

NO321237B1 (no

NO20001421D0 (no

Inventor

Leslie P Weiner

Jorge D Correale

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-19

Filing date

2000-03-17

Publication date

2000-05-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738869&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20001421(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-03-17 Application filed by Univ Southern California filed Critical Univ Southern California

2000-03-17 Publication of NO20001421D0 publication Critical patent/NO20001421D0/no

2000-05-19 Publication of NO20001421L publication Critical patent/NO20001421L/no

2006-04-10 Publication of NO321237B1 publication Critical patent/NO321237B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Rheumatology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20001421A 1997-09-19 2000-03-17 Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient. NO321237B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US5953497P	1997-09-19	1997-09-19
US09/156,509 US20020009448A1 (en)	1997-09-19	1998-09-17	T-cell vaccination for the treatment of multiple sclerosis
PCT/US1998/019572 WO1999013904A1 (en)	1997-09-19	1998-09-18	T-cell vaccination for the treatment of multiple sclerosis

Publications (3)

Publication Number	Publication Date
NO20001421D0 NO20001421D0 (no)	2000-03-17
NO20001421L true NO20001421L (no)	2000-05-19
NO321237B1 NO321237B1 (no)	2006-04-10

Family

ID=26738869

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001421A NO321237B1 (no)	1997-09-19	2000-03-17	Vaksiner, samt anvendelse av svekkede T-celler til fremstilling av et medikament for formidling av immunrespons i en pasient.

Country Status (8)

Country	Link
US (2)	US20020009448A1 (no)
EP (1)	EP1015025B1 (no)
AT (1)	ATE284708T1 (no)
AU (1)	AU755884B2 (no)
CA (1)	CA2304373A1 (no)
DE (1)	DE69828179D1 (no)
NO (1)	NO321237B1 (no)
WO (1)	WO1999013904A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050220908A1 (en) *	2004-03-30	2005-10-06	Theoharides Theoharis C	Anti-inflammatory compositions for multiple sclerosis
US7906153B2 (en) *	1998-04-08	2011-03-15	Theta Biomedical Consulting & Development Co., Inc.	Anti-inflammatory compositions for treating multiple sclerosis
US6541608B1 (en) *	1999-02-23	2003-04-01	Baylor College Of Medicine	T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
US7541184B2 (en) *	2000-02-24	2009-06-02	Invitrogen Corporation	Activation and expansion of cells
US7572631B2 (en)	2000-02-24	2009-08-11	Invitrogen Corporation	Activation and expansion of T cells
WO2002100428A1 (en)	2001-06-11	2002-12-19	Transition Therapeutics Inc.	Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
US7658926B2 (en) *	2001-09-14	2010-02-09	Opexa Pharmaceuticals, Inc.	Autologous T-cell vaccines materials and methods
US20040175373A1 (en) *	2002-06-28	2004-09-09	Xcyte Therapies, Inc.	Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20050084967A1 (en) *	2002-06-28	2005-04-21	Xcyte Therapies, Inc.	Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
ES2545736T3 (es) *	2002-08-08	2015-09-15	Baylor College Of Medicine	Aislamiento e identificación de células T
EP1583823A4 (en) *	2002-12-31	2006-02-22	Baylor College Medicine	ISOLATION AND IDENTIFICATION OF CROSS-REACTIVE T CELLS
DK2016414T3 (en) *	2006-05-05	2015-12-07	Opexa Therapeutics	T-cell vaccine
DK2318020T3 (en) *	2008-06-30	2015-11-30	Universitätsklinikum Heidelberg	Immunosuppressive blood cells and methods of producing same
SG11201809542XA (en)	2016-05-25	2018-12-28	Council Queensland Inst Medical Res	Methods of immunotherapy
KR20250067948A (ko) *	2017-01-20	2025-05-15	아타라 바이오테라퓨틱스 인크.	자가 t 세포를 사용하여 다발성 경화증을 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5114844A (en) *	1989-03-14	1992-05-19	Yeda Research And Development Co., Ltd.	Diagnosis and treatment of insulin dependent diabetes mellitus
IL97709A (en) *	1990-03-30	2005-05-17	Brigham & Womens Hospital	Use of an mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
US5849886A (en) *	1996-07-10	1998-12-15	Oy Aboatech Ab	Extraction of myelin basic protein
US7658926B2 (en) *	2001-09-14	2010-02-09	Opexa Pharmaceuticals, Inc.	Autologous T-cell vaccines materials and methods

1998
- 1998-09-17 US US09/156,509 patent/US20020009448A1/en not_active Abandoned
- 1998-09-18 CA CA002304373A patent/CA2304373A1/en not_active Abandoned
- 1998-09-18 EP EP98949378A patent/EP1015025B1/en not_active Revoked
- 1998-09-18 AT AT98949378T patent/ATE284708T1/de not_active IP Right Cessation
- 1998-09-18 AU AU95713/98A patent/AU755884B2/en not_active Ceased
- 1998-09-18 WO PCT/US1998/019572 patent/WO1999013904A1/en not_active Ceased
- 1998-09-18 DE DE69828179T patent/DE69828179D1/de not_active Expired - Lifetime
2000
- 2000-03-17 NO NO20001421A patent/NO321237B1/no not_active IP Right Cessation
2004
- 2004-02-05 US US10/773,356 patent/US20040156860A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1015025B1 (en)	2004-12-15
ATE284708T1 (de)	2005-01-15
EP1015025A1 (en)	2000-07-05
US20020009448A1 (en)	2002-01-24
CA2304373A1 (en)	1999-03-25
WO1999013904A1 (en)	1999-03-25
US20040156860A1 (en)	2004-08-12
AU9571398A (en)	1999-04-05
DE69828179D1 (de)	2005-01-20
AU755884B2 (en)	2003-01-02
NO321237B1 (no)	2006-04-10
NO20001421D0 (no)	2000-03-17

Publication	Publication Date	Title
NO20001421L (no)	2000-05-19	T-cellevaksinasjon for behandling av multippel sklerose
CY2612B2 (en)	2010-12-22	Compounds for immunotherapy and diagnosis of tuberculosis
NO983999D0 (no)	1998-08-31	Peptidimmunogener for vaksinasjon mot og behandling av allergi
NO931372L (no)	1993-05-18	Behandling av autoimmunsykdommer ved oral administrering av autoantigener
AU2002302255A1 (en)	2002-12-09	Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
ES2190784T3 (es)	2003-08-16	Supresion de enfermedades autoinmunes por antigenos espectadores.
MXPA02005576A (es)	2002-12-13	Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
DE69426077D1 (de)	2000-11-09	Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
NO20004614D0 (no)	2000-09-15	Mutante rekombinante allergener
DE69840383D1 (de)	2009-02-05	Ctl epitope des epstein-barr virus
DK0422186T3 (da)	1999-08-16	Anvendelse af oncostatin M til suppression af MHC-antigener
BG103141A (en)	1999-08-31	Composition of a malaria vaccine
PT876398E (pt)	2002-12-31	Inducao de respostas imunitarias contra determinantes desejados
ZA915230B (en)	1992-04-29	Ehv-4 glycoprotein vaccine
DK1024829T3 (da)	2009-02-09	Tolerogene fragmenter af naturlige allergener

Legal Events

Date	Code	Title	Description
2010-04-26	MM1K	Lapsed by not paying the annual fees